Status | Study |
Active, not recruiting |
Study Name: Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia Condition: Hyperinsulinemia Hypoglycemia Date: 2016-12-15 Interventions: Drug: Exendin (9-39) |
Not yet recruiting |
Study Name: Gastrectomy, Eating Behaviour and GLP-1 Condition: Gastric Cancer Dumping Syndrome Date: 2016-11-17 Interventions: Other: Exendin 9-39 Complete b |
Recruiting |
Study Name: Impact of an Educational Personalized Clinical Support Device Preventive and a Referent Nurse in Surgery for Obesity Condition: Dumping Syndrome Date: 2016-09-01 Interventions: Behavioral: Dietary and nutritional recommendations conducted by a nurse Supplementary dietary and nutri |
Recruiting |
Study Name: Metabolic Consequences of Gastrointestinal Surgery Condition: Gastrectomy Oesophagectomy Dumping S Date: 2016-07-13 Interventions: Drug: Somatostatin Single dose |
Recruiting |
Study Name: Dumping Syndrome After Operation of Esophageal Atresia Type III Condition: Oesophageal Atresia Dumping Syndrome Date: 2015-08-14 Interventions: Biological: Oral Glucose 1.75g/kg of glucose is orally taken by the patient. Capillary glycemia is syste |
Completed |
Study Name: SOMATULINE Autogel 90 mg IN DUMPING SYNDROME Condition: Dumping Syndrome Date: 2013-07-19 Interventions: Drug: Lanreotide 90 mg slow release formulation |
Completed |
Study Name: Study to Assess Safety and Efficacy of sc Pasireotide in Patients With Dumping Syndrome Condition: Postoperative Dumping Syndrome Date: 2013-07-01 Interventions: Drug: Pasireotide somatostatin |
Recruiting |
Study Name: Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study. Condition: Cushing's Disease Acromegaly Neuroendocrine Tumors Date: 2013-02-15 Interventions: Drug: Pasireotide Pasireotide subcutaneous or Long Acting Release |
Completed |
Study Name: Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome Condition: Dumping Syndrome Date: 2012-05-09 Interventions: Drug: SOM230 Pasireotide (SOM230) sc injection was provided as solution for injection in individual 1-po |
Completed |
Study Name: Treatment of the Dumping Syndrome With Lanreotide Autogel® Condition: Dumping Syndrome Date: 2007-10-11 Interventions: Drug: Somatuline (Lanreotide Autogel®) |